首页> 外国专利> METHOD FOR PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN LAPAROSCOPIC OPERATIONS FOR COLONIC ONCOLOGIC DISEASES

METHOD FOR PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN LAPAROSCOPIC OPERATIONS FOR COLONIC ONCOLOGIC DISEASES

机译:腹腔镜手术中预防慢性原发性疾病的静脉血栓形成并发症的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to vascular surgery, and can be used for prevention of venous thromboembolic complications in patients operated laparoscopically for oncologic diseases of large intestine. Overall blood test, a biochemical blood test, a blood coagulogram analysis are performed to determine the following parameters: fibrinogen level, platelet count in plasma, level of D-dimer, amount of soluble fibrin-monomer complexes, thrombin time, prothrombin time. Collecting complete history of the following: previous chemotherapeutic treatment, the presence or absence of venous thromboembolic complications, the use of anticoagulants, antiaggregants, taking into account the findings of ultrasound examination of veins of lower extremities and in the presence of three of the following factors: fibrinogen level  4 g/l, thrombocyte count  400 10 × 9 l, level of D-dimer  0.5 g/l, amount of soluble fibrin-monomer complexes  4 g/l, thrombin time  15 seconds, prothrombin time  8 seconds, diameter of large saphenous vein  7 mm is high risk of venous thromboembolic complications and 12 hours before performing laparoscopic operation low-molecular heparin is prescribed in dosage 6000 ME.;EFFECT: method improves results of operative treatment by reducing thromboembolic complications in patients with malignant large intestine formations operated laparoscopically.;1 cl, 4 ex
机译:技术领域本发明涉及药物,即血管外科手术,并且可以用于预防腹腔镜手术的大肠肿瘤患者的静脉血栓栓塞并发症。进行总体血液测试,生化血液测试,凝血图分析以确定以下参数:纤维蛋白原水平,血浆中的血小板计数,D-二聚体水平,可溶性纤维蛋白-单体复合物的量,凝血酶时间,凝血酶原时间。收集以下完整的病史:以前的化学治疗,是否存在静脉血栓栓塞并发症,使用抗凝剂,抗凝剂,并考虑到下肢静脉超声检查的发现以及以下三个因素的存在:纤维蛋白原水平> 4 g / l,血小板计数> 400 10×9 l,D-二聚体水平> 0.5 g / l,可溶性纤维蛋白单体复合物的量> 4 g / l,凝血酶时间<15秒,凝血酶原时间<8秒,大隐静脉的直径> 7 mm是静脉血栓栓塞并发症的高风险,并且在进行腹腔镜手术之前12小时以6000 ME的剂量处方低分子肝素;效果:该方法通过减少血栓栓塞并发症改善了手术治疗的结果腹腔镜手术的大肠恶性肿瘤患者; 1 cl,4 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号